Immobilization and magnetic extraction of pathogens and pathogen components
AssigneeFriedrich-Alexander-Universität Erlangen-Nürnberg
InventorsChristoph ALEXIOU, Stefan LYER, Rainer TIETZE, Bernhard FRIEDRICH
Life of this patent
Estimating the term…
Loading patent…
AssigneeFriedrich-Alexander-Universität Erlangen-Nürnberg
InventorsChristoph ALEXIOU, Stefan LYER, Rainer TIETZE, Bernhard FRIEDRICH
Estimating the term…
Immobilization and magnetic extraction of pathogens and pathogen components The application describes a method for reducing the concentration of pathogens and/or pathogen components in an aqueous or body fluid sample. Specifically, the method relates to incubating the sample with superparamagnetic iron-based particles attached to a target binding peptide and immobilising the superparamagnetic iron-based particles with a magnetic field and thereby separating the pathogen-bound and/or pathogen component-bound superparamagnetic iron-based particles from the sample. Furthermore, the application relates to a method for identifying pathogens in an aqueous or body fluid sample a use of superparamagnetic iron-based particles for reducing the concentration of pathogens and/or pathogen components in an aqueous or body fluid sample. In addition, a use of superparamagnetic iron-based particles for identifying pathogens in an aqueous or body fluid sample is disclosed. Finally, superparamagnetic ironoxide nanoparticles (SPION's) are disclosed, wherein the SPIONs are linked to a target binding peptide. wherein the target is a pathogen, and/or a pathogen component.
A method for reducing the concentration of pathogens and/or pathogen components in an aqueous or body fluid sample, the method comprising the steps of:
The method of any of the preceding claims, wherein the superparamagnetic iron-based particles are selected from and iron oxide, iron (Fe), iron-cobalt, alnico, permalloy particles, preferably wherein the superparamagnetic iron-based particles are superparamagnetic ironoxide nanoparticles (SPIONs).
The method of any of the preceding claims, wherein the sample is a body fluid sample, waste water, ground water, or drinking water, preferably wherein the body fluid sample is a human body fluid, more preferably wherein the human body fluid is selected from blood, serum, plasma, lymph, urine, liquor, saliva and sputum, even more preferably wherein the human body fluid is blood or serum, even more preferably wherein the human body fluid is blood, and most preferably wherein the blood is from a septic patient.
The method of any of preceding claims, wherein the concentration of pathogens and/or pathogen components in the sample of step (c) is reduced by at least 20%, preferably at least 25%, more preferably at least 30%, more preferably at least 35%, even more preferably at least 40%, even more preferably at least 45%, and even more preferably at least 50%, compared to the sample of step (a).
The method of any of the preceding claims, wherein the pathogens comprise bacteria, fungi and/or viruses, preferably wherein the pathogens are bacteria, preferably wherein the pathogens comprise gram-negative and/or a gram-positive bacteria, more preferably wherein the gram-negative bacteria are selected from one or more of Escherichia coli, Pseudomonas spp., and Klebsiella spp., and/or the gram-positive bacteria are selected from one or more of Staphylococcus aureus, Serratia, Streptococcus spp., Listeria monocytogenes, Clostridium difficile, and Enterobacter.
The method of any of the preceding claims, wherein the pathogen components comprise endotoxins and/or pathogenic cell wall components,
The method of any of the preceding claims, wherein the target binding peptide has a sequence comprising 12-30 amino acids having one motif selected from SEQ ID NO:
The method of any of the preceding claims, wherein the superparamagnetic iron-based particles are covalently linked to the target binding peptide via a connecting module;
The method of any of the preceding claims, wherein the superparamagnetic iron-based particles are SPIONs and wherein the SPIONs linked to a target binding peptide are capable of reducing the concentration of LPS in step (c) by at least 70%, preferably 80%, more preferably 90%, and even more preferably 95%, compared to the sample of step (a) comprising a LPS concentration of 10 EU/ml, wherein the reduction is determined after incubating the SPIONs linked to a target binding peptide at a concentration of 1 mg Fe/ml in Ringer solution followed by immobilising the SPIONs linked to a target binding peptide in a magnetic field of 0.31 Tesla for a time period of 30 seconds by using an assay based on the detection of recombinant factor C.
A method for identifying pathogens in an aqueous or body fluid sample, the method comprising the steps of
Superparamagnetic ironoxide nanoparticles (SPIONs), wherein the SPIONs are linked to a target binding peptide, wherein the target is a pathogen and/or a pathogen component, wherein the SPIONs are magnetically attractable and wherein the magnetic attractability is characterized by a reduction of the SPION concentration in water by 65% to 99.95% when applying a magnetic field of 0.31 Tesla for three minutes in static condition.
Dependencies are inferred from the claim text.